Replies to post #87959 on Biotech Values

[DewDiligence]

ACHN:

Are you implying that it was the VC shareholders that pressured ACHN into reporting the Phase 1b data early, presumably to report good returns for their VC fund for FY end?

Yes—that’s precisely what I’m implying.